The common PARK8 mutation LRRK2 G2019S is not a risk factor for breast cancer in the absence of Parkinson’s disease

2013 ◽  
Vol 260 (8) ◽  
pp. 2177-2178 ◽  
Author(s):  
H. Mortiboys ◽  
A. Cox ◽  
I. W. Brock ◽  
O. Bandmann
2021 ◽  
pp. 1-16
Author(s):  
Alison Fellgett ◽  
C. Adam Middleton ◽  
Jack Munns ◽  
Chris Ugbode ◽  
David Jaciuch ◽  
...  

Background: Inherited mutations in the LRRK2 protein are the common causes of Parkinson’s disease, but the mechanisms by which increased kinase activity of mutant LRRK2 leads to pathological events remain to be determined. In vitro assays (heterologous cell culture, phospho-protein mass spectrometry) suggest that several Rab proteins might be directly phosphorylated by LRRK2-G2019S. An in vivo screen of Rab expression in dopaminergic neurons in young adult Drosophila demonstrated a strong genetic interaction between LRRK2-G2019S and Rab10. Objective: To determine if Rab10 is necessary for LRRK2-induced pathophysiological responses in the neurons that control movement, vision, circadian activity, and memory. These four systems were chosen because they are modulated by dopaminergic neurons in both humans and flies. Methods: LRRK2-G2019S was expressed in Drosophila dopaminergic neurons and the effects of Rab10 depletion on Proboscis Extension, retinal neurophysiology, circadian activity pattern (‘sleep’), and courtship memory determined in aged flies. Results: Rab10 loss-of-function rescued LRRK2-G2019S induced bradykinesia and retinal signaling deficits. Rab10 knock-down, however, did not rescue the marked sleep phenotype which results from dopaminergic LRRK2-G2019S. Courtship memory is not affected by LRRK2, but is markedly improved by Rab10 depletion. Anatomically, both LRRK2-G2019S and Rab10 are seen in the cytoplasm and at the synaptic endings of dopaminergic neurons. Conclusion: We conclude that, in Drosophila dopaminergic neurons, Rab10 is involved in some, but not all, LRRK2-induced behavioral deficits. Therefore, variations in Rab expression may contribute to susceptibility of different dopaminergic nuclei to neurodegeneration seen in people with Parkinson’s disease.


2013 ◽  
Vol 37 (10) ◽  
pp. 1550-1563 ◽  
Author(s):  
Bianca Marchetti ◽  
Francesca L'Episcopo ◽  
Maria Concetta Morale ◽  
Cataldo Tirolo ◽  
Nuccio Testa ◽  
...  

2015 ◽  
Vol 355 (1-2) ◽  
pp. 72-74 ◽  
Author(s):  
Leyla Haghnejad ◽  
Babak Emamalizadeh ◽  
Javad Jamshidi ◽  
Alireza Zare Bidoki ◽  
Hamid Ghaedi ◽  
...  

2012 ◽  
Vol 131 (8) ◽  
pp. 1904-1911 ◽  
Author(s):  
Kathrine Rugbjerg ◽  
Søren Friis ◽  
Christina Funch Lassen ◽  
Beate Ritz ◽  
Jørgen H. Olsen

Sign in / Sign up

Export Citation Format

Share Document